Literature DB >> 6795141

Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients.

A I Hartstein, S B Garber, T T Ward, S R Jones, V H Morthland.   

Abstract

This study describes the evaluation of 108 patients who had indwelling urethral catheters for acute medical and surgical indications. Patients were evaluated daily, and cultures from bladders and drainage bags were obtained. Appropriateness for continuing catheterization was assessed using preset criteria. Twenty-five patients developed urinary tract infections. Exposure to antibiotics and a shorter duration of catheterization were the only factors that correlated significantly with a delayed onset or decreased prevalence of infection. Factors found to have insignificant effects included age, sex, maintenance of the closed system, underlying host disease status, catheter type, and reason for catheterization. No collection systems with one way valves were used, but significantly colony counts in drainage bag urine preceded urinary tract infection in only two patients. Thirty-six percent of the total 562 catheter days were judged unnecessary. A major emphasis must be placed on prompt catheter removal if the prevalence of nosocomial urinary tract infections is to be reduced substantially in a cost-effective manner.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795141     DOI: 10.1017/s0195941700055533

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  14 in total

Review 1.  Treatment of urinary tract infection. Clinical and economic considerations.

Authors:  R J Plumridge; C L Golledge
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

2.  Culture-dependent and -independent investigations of microbial diversity on urinary catheters.

Authors:  Yijuan Xu; Claus Moser; Waleed Abu Al-Soud; Søren Sørensen; Niels Høiby; Per Halkjær Nielsen; Trine Rolighed Thomsen
Journal:  J Clin Microbiol       Date:  2012-09-26       Impact factor: 5.948

Review 3.  Catheter-Associated Urinary Tract Infections in Adult Patients.

Authors:  Jennifer Kranz; Stefanie Schmidt; Florian Wagenlehner; Laila Schneidewind
Journal:  Dtsch Arztebl Int       Date:  2020-02-07       Impact factor: 5.594

4.  Candiduria: prevalence and trends in antifungal susceptibility in a tertiary care hospital of mangalore.

Authors:  Yashavanth R; Shiju M P; Bhaskar U A; Ronald R; Anita K B
Journal:  J Clin Diagn Res       Date:  2013-11-10

5.  Comparison of uropathogens and antibiotic susceptibility patterns in catheterized ambulant middle-aged and elderly Nigerian patients with bladder outlet obstruction.

Authors:  Patrick Temi Adegun; Michael Simidele Odimayo; Julius Gbenga Olaogun; Eyitayo Ebenezer Emmanuel
Journal:  Turk J Urol       Date:  2018-06-05

6.  Bladder catheterization increases susceptibility to infection that can be prevented by prophylactic antibiotic treatment.

Authors:  Matthieu Rousseau; H M Sharon Goh; Sarah Holec; Matthew L Albert; Rohan Bh Williams; Molly A Ingersoll; Kimberly A Kline
Journal:  JCI Insight       Date:  2016-09-22

Review 7.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 8.  Prevention and treatment of urinary catheter-related infections in older patients.

Authors:  L E Nicolle
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

9.  Nosocomial urinary tract infections caused by extended-spectrum beta-lactamase uropathogens: Prevalence, pathogens, risk factors, and strategies for infection control.

Authors:  Khaireddine Bouassida; Mehdi Jaidane; Olfa Bouallegue; Ghassen Tlili; Habiba Naija; Ali Tahar Mosbah
Journal:  Can Urol Assoc J       Date:  2016 Mar-Apr       Impact factor: 1.862

10.  Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections.

Authors:  Pascale S Guiton; Thomas J Hannan; Bradley Ford; Michael G Caparon; Scott J Hultgren
Journal:  Infect Immun       Date:  2012-11-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.